LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,423 | +128.3% | 120,572 | +379.6% | 0.00% | – |
| Q2 2023 | $57,571 | +27.7% | 25,140 | +35.5% | 0.00% | – |
| Q1 2023 | $45,081 | +186.4% | 18,552 | +125.1% | 0.00% | – |
| Q4 2022 | $15,738 | -100.0% | 8,240 | -46.7% | 0.00% | – |
| Q3 2022 | $37,102,000 | +23.9% | 15,459 | -4.0% | 0.00% | – |
| Q2 2022 | $29,952,000 | -86.6% | 16,103 | -84.9% | 0.00% | – |
| Q1 2022 | $222,719,000 | -45.3% | 106,564 | +3.1% | 0.00% | -100.0% |
| Q4 2021 | $407,175,000 | +455.4% | 103,344 | +578.1% | 0.00% | – |
| Q3 2021 | $73,309,000 | +479.3% | 15,241 | +452.8% | 0.00% | – |
| Q2 2021 | $12,655,000 | -68.3% | 2,757 | -59.4% | 0.00% | – |
| Q1 2021 | $39,904,000 | +48.5% | 6,798 | -13.5% | 0.00% | – |
| Q4 2020 | $26,864,000 | +95.8% | 7,855 | -17.6% | 0.00% | – |
| Q3 2020 | $13,719,000 | +139.3% | 9,527 | +231.5% | 0.00% | – |
| Q2 2020 | $5,734,000 | -78.6% | 2,874 | -79.1% | 0.00% | – |
| Q1 2020 | $26,754,000 | +12.5% | 13,720 | +139.5% | 0.00% | – |
| Q4 2019 | $23,771,000 | +2.4% | 5,728 | -25.7% | 0.00% | – |
| Q3 2019 | $23,219,000 | -35.2% | 7,714 | +35.5% | 0.00% | – |
| Q2 2019 | $35,809,000 | -35.2% | 5,693 | -42.7% | 0.00% | – |
| Q1 2019 | $55,233,000 | +771.0% | 9,934 | +940.2% | 0.00% | – |
| Q4 2018 | $6,341,000 | -77.3% | 955 | -63.5% | 0.00% | – |
| Q3 2018 | $27,913,000 | -4.4% | 2,616 | +7.6% | 0.00% | – |
| Q2 2018 | $29,184,000 | -63.7% | 2,432 | -74.1% | 0.00% | – |
| Q1 2018 | $80,387,000 | -11.5% | 9,380 | +2.0% | 0.00% | – |
| Q4 2017 | $90,856,000 | +44.0% | 9,196 | +79.1% | 0.00% | – |
| Q3 2017 | $63,109,000 | -29.6% | 5,135 | -5.7% | 0.00% | – |
| Q2 2017 | $89,587,000 | +587.3% | 5,446 | +499.1% | 0.00% | – |
| Q1 2017 | $13,035,000 | -31.4% | 909 | -33.8% | 0.00% | – |
| Q4 2016 | $18,989,000 | -70.2% | 1,373 | -61.0% | 0.00% | – |
| Q3 2016 | $63,624,000 | +169.0% | 3,521 | +113.7% | 0.00% | – |
| Q2 2016 | $23,649,000 | -80.3% | 1,648 | -81.7% | 0.00% | – |
| Q4 2015 | $120,002,000 | +26.3% | 9,016 | +1.9% | 0.00% | – |
| Q3 2015 | $95,006,000 | – | 8,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |